Lindbrook Capital’s SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-15,246
| Closed | -$1.37M | – | 2949 |
|
|
2024
Q4 | $1.37M | Sell |
15,246
-7,360
| -33% | -$663K | 0.12% | 102 |
|
|
2024
Q3 | $2.23M | Sell |
22,606
-16,568
| -42% | -$1.64M | 0.2% | 73 |
|
|
2024
Q2 | $3.63M | Sell |
39,174
-14,354
| -27% | -$1.33M | 0.34% | 51 |
|
|
2024
Q1 | $5.08M | Buy |
53,528
+5,573
| +12% | +$529K | 0.48% | 40 |
|
|
2023
Q4 | $4.28M | Buy |
47,955
+308
| +0.6% | +$27.5K | 0.43% | 44 |
|
|
2023
Q3 | $3.48M | Buy |
47,647
+560
| +1% | +$40.9K | 0.39% | 46 |
|
|
2023
Q2 | $3.92M | Buy |
47,087
+1,244
| +3% | +$104K | 0.42% | 43 |
|
|
2023
Q1 | $3.49M | Buy |
45,843
+675
| +1% | +$51.4K | 0.41% | 47 |
|
|
2022
Q4 | $3.75M | Buy |
+45,168
| New | +$3.75M | 0.46% | 46 |
|
|
2022
Q1 | – | Sell |
-38
| Closed | -$4K | – | 2638 |
|
|
2021
Q4 | $4K | Buy |
+38
| New | +$4K | ﹤0.01% | 1617 |
|
|
2021
Q2 | – | Sell |
-158
| Closed | -$21K | – | 2015 |
|
|
2021
Q1 | $21K | Hold |
158
| – | – | ﹤0.01% | 744 |
|
|
2020
Q4 | $22K | Hold |
158
| – | – | 0.01% | 655 |
|
|
2020
Q3 | $18K | Hold |
158
| – | – | 0.01% | 654 |
|
|
2020
Q2 | $18K | Hold |
158
| – | – | 0.01% | 652 |
|
|
2020
Q1 | $12K | Hold |
158
| – | – | ﹤0.01% | 709 |
|
|
2019
Q4 | $15K | Hold |
158
| – | – | 0.01% | 819 |
|
|
2019
Q3 | $12K | Buy |
158
+1
| +0.6% | +$76 | ﹤0.01% | 854 |
|
|
2019
Q2 | $13K | Hold |
157
| – | – | 0.01% | 825 |
|
|
2019
Q1 | $14K | Hold |
157
| – | – | 0.01% | 803 |
|
|
2018
Q4 | $11K | Buy |
+157
| New | +$11K | 0.01% | 808 |
|